WHO ICTRP trial
BLISS-POST
JPRN-jRCTs071190045 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs071190045 |
|---|---|
| Public title | BLISS-POST |
| Scientific title | Glucocorticoid-tapering aimed maintenance therapy in patients with systemic lupus erythematosus |
| Primary sponsor | Tanaka Yoshiya |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Systemic Lupus Erythematosus Systemic Lupus Erythematosus;D008180;Systemic Lupus Erythematosus |
| Interventions | The patient begins berimumab with a half-dose reduction in steroids at week 8, a further half-dose reduction at week 16, and discontinuation of steroids at week 24. The investigator periodically assesses disease activity and discontinues… |
| Registration date | Feb 14, 2020 |
| Target size | 100 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: